138 related articles for article (PubMed ID: 23036582)
21. Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line.
Imaizumi A; Onishi H; Yamasaki A; Kawamoto M; Umebayashi M; Morisaki T; Hasumi K
Anticancer Res; 2016 Feb; 36(2):653-7. PubMed ID: 26851020
[TBL] [Abstract][Full Text] [Related]
22. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
[TBL] [Abstract][Full Text] [Related]
23. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine.
Gao CC; Xu XL; Li F; Gong BG; Liu S; Cui YQ; Sun HC; Xu PY; Zheng YM; Jiang H
Tumour Biol; 2016 Jun; 37(6):7555-64. PubMed ID: 26684804
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.
Shimizu K; Chiba S; Hori Y
PLoS One; 2013; 8(11):e81283. PubMed ID: 24278411
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells.
Zhang SN; Huang FT; Huang YJ; Zhong W; Yu Z
Tumori; 2010; 96(6):985-92. PubMed ID: 21388063
[TBL] [Abstract][Full Text] [Related]
26. CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2.
Chen X; Zheng P; Xue Z; Li J; Wang W; Chen X; Xie F; Yu Z; Ouyang X
Apoptosis; 2013 Jul; 18(7):861-9. PubMed ID: 23463283
[TBL] [Abstract][Full Text] [Related]
27. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells.
Jiang PH; Motoo Y; Sawabu N; Minamoto T
World J Gastroenterol; 2006 Mar; 12(10):1597-602. PubMed ID: 16570353
[TBL] [Abstract][Full Text] [Related]
28. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
29. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
[TBL] [Abstract][Full Text] [Related]
30. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
Ozaki T; Nakamura M; Ogata T; Sang M; Yoda H; Hiraoka K; Sang M; Shimozato O
Oncotarget; 2016 Nov; 7(44):71937-71950. PubMed ID: 27713122
[TBL] [Abstract][Full Text] [Related]
31. Systemic Administration of Small Interfering RNA Targeting Human Nestin Inhibits Pancreatic Cancer Cell Proliferation and Metastasis.
Matsuda Y; Ishiwata T; Yoshimura H; Yamashita S; Ushijima T; Arai T
Pancreas; 2016 Jan; 45(1):93-100. PubMed ID: 26335012
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase.
Funamizu N; Kamata Y; Misawa T; Uwagawa T; Lacy CR; Yanaga K; Manome Y
Pancreas; 2012 Jan; 41(1):107-13. PubMed ID: 21926937
[TBL] [Abstract][Full Text] [Related]
33. Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.
World J Gastroenterol; ; . PubMed ID: 18609717
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
